ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial
The Lancet
◽
10.1016/s0140-6736(14)61942-5
◽
2015
◽
Vol 385
(9981)
◽
pp. 1957-1965
◽
Cited By ~ 300
Author(s):
Michel Azizi
◽
Marc Sapoval
◽
Philippe Gosse
◽
Matthieu Monge
◽
Guillaume Bobrie
◽
...
Keyword(s):
Randomised Controlled Trial
◽
Resistant Hypertension
◽
Antihypertensive Treatment
◽
Renal Denervation
◽
Controlled Trial
◽
Stepped Care
◽
Open Label
◽
Randomised Controlled
Download Full-text
Related Documents
Cited By
References
Renal denervation for resistant hypertensionSymplicity HTN-2 Investigators Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Böhm M, (2011) Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 376 1903–9
British Journal of Cardiac Nursing
◽
10.12968/bjca.2011.6.2.94
◽
2011
◽
Vol 6
(2)
◽
pp. 94-94
◽
Cited By ~ 2
Author(s):
Belinda Linden
Keyword(s):
Randomised Controlled Trial
◽
Resistant Hypertension
◽
Renal Denervation
◽
Controlled Trial
◽
Sympathetic Denervation
◽
Renal Sympathetic Denervation
◽
Treatment Resistant
◽
Randomised Controlled
◽
Renal Sympathetic
Download Full-text
Faculty Opinions recommendation of Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.1166102.628092
◽
2009
◽
Author(s):
Jim Orr
◽
Fadi Abu Shahin
Keyword(s):
Ovarian Cancer
◽
Randomised Controlled Trial
◽
Controlled Trial
◽
Advanced Ovarian Cancer
◽
Open Label
◽
Phase 3
◽
Dose Dense
◽
Randomised Controlled
Download Full-text
Faculty Opinions recommendation of Gatifloxacin versus chloramphenicol for uncomplicated enteric fever: an open-label, randomised, controlled trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.12032956.13172054
◽
2011
◽
Author(s):
Carlos Seas
◽
Jorge Alave
Keyword(s):
Randomised Controlled Trial
◽
Enteric Fever
◽
Controlled Trial
◽
Open Label
◽
Randomised Controlled
Download Full-text
Faculty Opinions recommendation of Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.13368964.14739064
◽
2011
◽
Author(s):
Vineet Bhandari
Keyword(s):
Mechanical Ventilation
◽
Randomised Controlled Trial
◽
Preterm Infants
◽
Controlled Trial
◽
Open Label
◽
Surfactant Treatment
◽
Randomised Controlled
◽
Spontaneously Breathing
Download Full-text
Faculty Opinions recommendation of Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.13827960.15267062
◽
2012
◽
Author(s):
Weijing Sun
◽
Davendra Sohal
Keyword(s):
Gastric Cancer
◽
Randomised Controlled Trial
◽
Controlled Trial
◽
Open Label
◽
Phase 3
◽
D2 Gastrectomy
◽
Randomised Controlled
Download Full-text
Faculty Opinions recommendation of Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.717548124.793152981
◽
2012
◽
Author(s):
Mitesh Borad
Keyword(s):
Randomised Controlled Trial
◽
Minimally Invasive
◽
Oesophageal Cancer
◽
Controlled Trial
◽
Open Label
◽
Randomised Controlled
Download Full-text
Faculty Opinions recommendation of Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.717548124.793003137
◽
2012
◽
Author(s):
Tim Underwood
Keyword(s):
Randomised Controlled Trial
◽
Minimally Invasive
◽
Oesophageal Cancer
◽
Controlled Trial
◽
Open Label
◽
Randomised Controlled
Download Full-text
Faculty Opinions recommendation of Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, randomised controlled trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.717995519.793476076
◽
2013
◽
Author(s):
Kellie Mathis
Keyword(s):
Randomised Controlled Trial
◽
Controlled Trial
◽
Intraepithelial Neoplasia
◽
Anal Intraepithelial Neoplasia
◽
Hiv Positive
◽
Open Label
◽
Sex With Men
◽
Randomised Controlled
◽
Hiv Positive Men
Download Full-text
Faculty Opinions recommendation of Cervical pessaries for prevention of preterm birth in women with a multiple pregnancy (ProTWIN): a multicentre, open-label randomised controlled trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.718061912.793482586
◽
2013
◽
Author(s):
Jane Norman
Keyword(s):
Preterm Birth
◽
Randomised Controlled Trial
◽
Controlled Trial
◽
Multiple Pregnancy
◽
Open Label
◽
Randomised Controlled
Download Full-text
Faculty Opinions recommendation of 2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): an open-label, randomised controlled trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.718043513.793482079
◽
2013
◽
Author(s):
Ana Maria Gonzalez-Angulo
Keyword(s):
Breast Cancer
◽
Randomised Controlled Trial
◽
Controlled Trial
◽
Her2 Positive
◽
Open Label
◽
Adjuvant Trastuzumab
◽
Her2 Positive Breast Cancer
◽
Randomised Controlled
◽
Positive Breast Cancer
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close